0001493152-20-001391.txt : 20200130 0001493152-20-001391.hdr.sgml : 20200130 20200130171629 ACCESSION NUMBER: 0001493152-20-001391 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200130 DATE AS OF CHANGE: 20200130 EFFECTIVENESS DATE: 20200130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hoverink Biotechnologies, Inc. CENTRAL INDEX KEY: 0001586494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463590875 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359414 FILM NUMBER: 20562315 BUSINESS ADDRESS: STREET 1: 1801 CENTURY PARK EAST STREET 2: 24TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 424 772 2191 MAIL ADDRESS: STREET 1: 1801 CENTURY PARK EAST STREET 2: 24TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: Hoverink International Holdings Inc. DATE OF NAME CHANGE: 20140717 FORMER COMPANY: FORMER CONFORMED NAME: Sky Run Acqusition Corp DATE OF NAME CHANGE: 20130911 D 1 primary_doc.xml X0708 D LIVE 0001586494 Hoverink Biotechnologies, Inc. 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA CALIFORNIA 90067 866-443-4666 DELAWARE Hoverink Int, Holdings Inc Hoverink International Holdings Inc. Sky Run Acqusition Corp Corporation true Cyrus Sajna 1801 PARK EAST 24 Floor Los Angeles CA CALIFORNIA 90067 Executive Officer Director Davidra Nicole Sajna 1801 PARK EAST 24 Floor Los Angeles CA CALIFORNIA 90067 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false true true true true Common Stock false 0 None None None None NONE NONE XX Unknown XX All States false 8389900 0 8389900 true 0 0 0 0 0 We intend to use the proceeds from this offering to: Repay existing debt and R&D Expenses and for working capital. false Hoverink Biotechnologies, Inc. /s/ Cyrus Sajna Cyrus Sajna CEO 2020-01-30